Burden analysis of malignant neoplasms of bone and articular cartilage in China: Epidemiological trends and future projections based on the global burden of disease study

This study investigates the epidemiological trends of malignant neoplasms of bone and articular cartilage (MNBAC) in China from 1992 to 2021, examines their association with age-period-cohort factors, and forecasts the future epidemiological trends of MNBAC for the period 2022 to 2031. Data on the incidence, prevalence, mortality, and disability-adjusted life years associated with MNBAC were sourced from the Global Burden of Disease 2021 database. Temporal trends were analyzed through age-standardized rates (ASR) and estimated annual percentage changes to capture variations over time. An age-period-cohort analysis was performed to evaluate the impact of demographic and temporal factors. Additionally, future trends for 2022 to 2031 were forecasted using the auto-regressive integrated moving average modeling approach. From 1992 to 2021, the incidence, prevalence, mortality, and disability-adjusted life years rates of MNBAC in China showed a consistent overall increase, despite a downward trend in ASR. As of 2021, the age-standardized incidence rate was recorded at 1.4 per 100,000 (95% uncertainty intervals: 0.9-1.9), with an estimated annual percentage changes of 3.27 (95% confidence intervals: 2.57-3.98). Males exhibited markedly higher rates across all metrics compared to females. The disease burden followed a bimodal age distribution, disproportionately affecting adolescents and older adults. Projections for 2022 to 2031 indicate declines in age-standardized metrics but an absolute increase in case numbers, primarily attributed to population growth and aging demographics. This analysis underscores the growing burden of MNBAC in China, marked by higher rates in males and a bimodal age distribution affecting adolescents and the elderly. While ASR are anticipated to decline in the coming decade, the overall disease burden is likely to rise persistently. These findings provide valuable insights into the epidemiological trends and determinants of MNBAC, forming a basis for targeted interventions and future research priorities.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2025-12-19
DOI
https://doi.org/10.1097/md.0000000000046472
Primary Topic
Bone and Joint Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Burden analysis of malignant neoplasms of bone and articular cartilage in China: Epidemiological trends and future projections based on the global burden of disease study

Wensheng Zhang, Yuke Song, Le Ma
Medicine
Bone and Joint Diseases
article

Burden analysis of malignant neoplasms of bone and articular cartilage in China: Epidemiological trends and future projections based on the global burden of disease study

Wensheng Zhang, Yuke Song, Le Ma
article en

Abstract

This study investigates the epidemiological trends of malignant neoplasms of bone and articular cartilage (MNBAC) in China from 1992 to 2021, examines their association with age-period-cohort factors, and forecasts the future epidemiological trends of MNBAC for the period 2022 to 2031. Data on the incidence, prevalence, mortality, and disability-adjusted life years associated with MNBAC were sourced from the Global Burden of Disease 2021 database. Temporal trends were analyzed through age-standardized rates (ASR) and estimated annual percentage changes to capture variations over time. An age-period-cohort analysis was performed to evaluate the impact of demographic and temporal factors. Additionally, future trends for 2022 to 2031 were forecasted using the auto-regressive integrated moving average modeling approach. From 1992 to 2021, the incidence, prevalence, mortality, and disability-adjusted life years rates of MNBAC in China showed a consistent overall increase, despite a downward trend in ASR. As of 2021, the age-standardized incidence rate was recorded at 1.4 per 100,000 (95% uncertainty intervals: 0.9-1.9), with an estimated annual percentage changes of 3.27 (95% confidence intervals: 2.57-3.98). Males exhibited markedly higher rates across all metrics compared to females. The disease burden followed a bimodal age distribution, disproportionately affecting adolescents and older adults. Projections for 2022 to 2031 indicate declines in age-standardized metrics but an absolute increase in case numbers, primarily attributed to population growth and aging demographics. This analysis underscores the growing burden of MNBAC in China, marked by higher rates in males and a bimodal age distribution affecting adolescents and the elderly. While ASR are anticipated to decline in the coming decade, the overall disease burden is likely to rise persistently. These findings provide valuable insights into the epidemiological trends and determinants of MNBAC, forming a basis for targeted interventions and future research priorities.

MedicineVol. 104(51)
The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 48%
Bone and Joint Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.